[1] Yao SS, Cao GY, Han L, Chen ZS, Huang ZT, Gong P, et al. Prevalence and patterns of multimorbidity in a nationally representative sample of older Chinese: results from the China health and retirement longitudinal study. J Gerontol A Biol Sci Med Sci 2020;75(10):1974 − 80.
[2] He K, Zhang WL, Hu XQ, Zhao H, Guo BX, Shi Z, et al. Relationship between multimorbidity, disease cluster and all-cause mortality among older adults: a retrospective cohort analysis. BMC Public Health 2021;21(1):1080.
[3] Chen H, Cheng ML, Zhuang Y, Broad JB. Multimorbidity among middle-aged and older persons in urban China: prevalence, characteristics and health service utilization. Geriatr Gerontol Int 2018;18(10):1447 − 52.
[4] Gordon EH, Peel NM, Hubbard RE. The male-female health-survival paradox in hospitalised older adults. Maturitas 2018;107:13 − 8.
[5] Zhong QP, Tan YX, Chen WD, Huang HQ, Huang J, Li SJ, et al. Disease burden of schizophrenia patients visiting a Chinese regional mental health centre. J Comp Eff Res 2020;9(7):469 − 81.
[6] Chen H, Chen Y, Cui B. The association of multimorbidity with healthcare expenditure among the elderly patients in Beijing, China. Arch Gerontol Geriatr 2018;79:32 − 8.
[7] Zhao SQ, Zhao LP, Xu XP, You H. Individual-level health care costs attributable to noncommunicable diseases: a longitudinal study based on the older adults in China. Inquiry 2023;60:1-12.469580231214469. http://dx.doi.org/10.1177/00469580231214469.
[8] Cheung JTK, Yu R, Woo J. Is polypharmacy beneficial or detrimental for older adults with cardiometabolic multimorbidity? Pooled analysis of studies from Hong Kong and Europe. Fam Pract 2020;37(6):793 − 800.
[9] Dowrick C. Patient-centred care for multimorbidity: an end in itself? Lancet 2018;392(10141):4-5. http://dx.doi.org/10.1016/S0140-6736(18)31386-2.
[10] Zhao XY, Zhang Q, Ma C, Liu HY, Chen Y. Association between multimorbidity patterns and healthcare costs among middle-aged and older adults in China. Arch Gerontol Geriatr 2023;109:104959.